{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:52:25Z","timestamp":1761519145499,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T00:00:00Z","timestamp":1452729600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["DEC-2012\/07\/N\/NZ5\/01736"],"award-info":[{"award-number":["DEC-2012\/07\/N\/NZ5\/01736"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Polpharma Scientific Fundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s12020-015-0855-8","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T06:20:12Z","timestamp":1452752412000},"page":"497-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves\u2019 opthalmopathy"],"prefix":"10.1007","volume":"53","author":[{"given":"Nadia","family":"Sawicka-Gutaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart\u0142omiej","family":"Budny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"Zybek-Kocik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Sowi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Ziemnicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Walig\u00f3rska-Stachura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Rucha\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"issue":"2","key":"855_CR1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/MCB.14.2.1431","volume":"14","author":"B Samal","year":"1994","unstructured":"B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, I. McNiece, Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol. Cell. Biol. 14(2), 1431\u20131437 (1994)","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"855_CR2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00125-006-0173-z","volume":"49","author":"C Curat","year":"2006","unstructured":"C. Curat, V. Wegner, C. Sengenes, A. Miranville, C. Tonus, R. Busse, A. Bouloumie, Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49(4), 744\u2013747 (2006)","journal-title":"Diabetologia"},{"issue":"5","key":"855_CR3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s00125-010-2042-z","volume":"54","author":"D Friebe","year":"2011","unstructured":"D. Friebe, M. Neef, J. Kratzsch, S. Erbs, K. Dittrich, A. Garten, S. Petzold-Quinque, S. Bluher, T. Reinehr, M. Stumvoll, Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)\/pre-B cell colony (PBEF)\/visfatin linking obesity and inflammation in humans. Diabetologia 54(5), 1200\u20131211 (2011)","journal-title":"Diabetologia"},{"issue":"1","key":"855_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1210\/jc.2005-1475","volume":"91","author":"MP Chen","year":"2006","unstructured":"M.P. Chen, F.M. Chung, D.M. Chang, J.C. Tsai, H.F. Huang, S.J. Shin, Y.J. Lee, Elevated plasma level of visfatin\/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 91(1), 295\u2013299 (2006). doi: 10.1210\/jc.2005-1475","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"855_CR5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5603\/EP.2014.0019","volume":"65","author":"M Wojcik","year":"2014","unstructured":"M. Wojcik, M. Chmielewska-Kassassir, K. Grzywnowicz, L. Wozniak, K. Cypryk, The relationship between adipose tissue-derived hormones and gestational diabetes mellitus (GDM). Endokrynol. Polska 65(2), 134\u2013142 (2014)","journal-title":"Endokrynol. Polska"},{"issue":"5","key":"855_CR6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2265.2009.03546.x","volume":"71","author":"A Caixas","year":"2009","unstructured":"A. Caixas, R. Tirado, J. Vendrell, L. Gallart, A. Megia, I. Simon, G. Llaurado, J. Gonzalez-Clemente, O. Gimenez-Palop, Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters. Clin. Endocrinol. 71(5), 733\u2013738 (2009)","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"855_CR7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF03346482","volume":"32","author":"M Ozkaya","year":"2009","unstructured":"M. Ozkaya, M. Sahin, E. Cakal, F. Yuzbasioglu, K. Sezer, M. Kilinc, S.S. Imrek, Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. J. Endocrinol. Invest. 32(5), 435\u2013439 (2009)","journal-title":"J. Endocrinol. Invest."},{"key":"855_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-nutr-071811-150746","volume":"32","author":"TB Dahl","year":"2012","unstructured":"T.B. Dahl, S. Holm, P. Aukrust, B. Halvorsen, Visfatin\/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology. Annu. Rev. Nutr. 32, 229\u2013243 (2012)","journal-title":"Annu. Rev. Nutr."},{"key":"855_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3506-z","author":"N Sawicka-Gutaj","year":"2015","unstructured":"N. Sawicka-Gutaj, J. Waligorska-Stachura, M. Andrusiewicz, M. Biczysko, J. Sowinski, J. Skrobisz, M. Ruchala, Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin\/survivin DEx3 expression. Tumor Biol. (2015). doi: 10.1007\/s13277-015-3506-z","journal-title":"Tumor Biol."},{"issue":"5","key":"855_CR10","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1007\/s13277-013-1527-z","volume":"35","author":"K Zhang","year":"2014","unstructured":"K. Zhang, B. Zhou, P. Zhang, Z. Zhang, P. Chen, Y. Pu, Y. Song, L. Zhang, Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group. Tumor Biol. 35(5), 4031\u20134040 (2014)","journal-title":"Tumor Biol."},{"issue":"3","key":"855_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tem.2008.10.004","volume":"20","author":"A Garten","year":"2009","unstructured":"A. Garten, S. Petzold, A. Korner, S. Imai, W. Kiess, Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol. Metab. 20(3), 130\u2013138 (2009). doi: 10.1016\/j.tem.2008.10.004","journal-title":"Trends Endocrinol. Metab."},{"issue":"9","key":"855_CR12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0961203309103582","volume":"18","author":"CP Chung","year":"2009","unstructured":"C.P. Chung, A.G. Long, J.F. Solus, Y.H. Rho, A. Oeser, P. Raggi, C.M. Stein, Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus 18(9), 799\u2013806 (2009)","journal-title":"Lupus"},{"issue":"9","key":"855_CR13","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/art.22833","volume":"56","author":"F Brentano","year":"2007","unstructured":"F. Brentano, O. Schorr, C. Ospelt, J. Stanczyk, R.E. Gay, S. Gay, D. Kyburz, Pre-B cell colony-enhancing factor\/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix- degrading activities. Arthritis Rheum. 56(9), 2829\u20132839 (2007)","journal-title":"Arthritis Rheum."},{"issue":"1","key":"855_CR14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mrfmmm.2009.06.012","volume":"690","author":"AR Moschen","year":"2010","unstructured":"A.R. Moschen, S. Geiger, R. Gerner, H. Tilg, Pre-B cell colony enhancing factor\/NAMPT\/visfatin and its role in inflammation-related bone disease. Mutat. Res. 690(1), 95\u2013101 (2010)","journal-title":"Mutat. Res."},{"issue":"2","key":"855_CR15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2133.2012.10980.x","volume":"167","author":"S Ismail","year":"2012","unstructured":"S. Ismail, S. Mohamed, Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity. Br. J. Dermatol. 167(2), 436\u2013439 (2012)","journal-title":"Br. J. Dermatol."},{"issue":"22","key":"855_CR16","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.3748\/wjg.v20.i22.6912","volume":"20","author":"M Waluga","year":"2014","unstructured":"M. Waluga, M. Hartleb, G. Boryczka, M. Kukla, K. Zwirska-Korczala, Serum adipokines in inflammatory bowel disease. World J Gastroenterol 20(22), 6912 (2014)","journal-title":"World J Gastroenterol"},{"issue":"3","key":"855_CR17","first-page":"226","volume":"64","author":"M Olszanecka-Glinianowicz","year":"2013","unstructured":"M. Olszanecka-Glinianowicz, G. Handzlik-Orli, B. Orlik, J. Chudek, Adipokines in the pathogenesis of idiopathic inflammatory bowel disease. Endokrynol. Polska 64(3), 226\u2013231 (2013)","journal-title":"Endokrynol. Polska"},{"key":"855_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103495","author":"O Sglunda","year":"2014","unstructured":"O. Sglunda, H. Mann, H. Hulejova, M. Kuklova, O. Pecha, L. Plestilova, M. Filkova, K. Pavelka, J.\u0102. Vencovsky, L. Senolt, Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort. PLoS One (2014). doi: 10.1371\/journal.pone.0103495","journal-title":"PLoS One"},{"issue":"4","key":"855_CR19","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1530\/EC-13-0061","volume":"2","author":"N Cinar","year":"2013","unstructured":"N. Cinar, A. Gurlek, Association between novel adipocytokines adiponectin, vaspin, visfatin, and thyroid: an experimental and clinical update. Endocr. Connect. 2(4), R30\u2013R38 (2013)","journal-title":"Endocr. Connect."},{"issue":"4","key":"855_CR20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5603\/EP.2015.0046","volume":"66","author":"N Sawicka-Gutaj","year":"2015","unstructured":"N. Sawicka-Gutaj, T. Bednarczuk, J. Daroszewski, J. Walig\u00f3rska-Stachura, P. Mi\u015bkiewicz, J. Sowi\u0144ski, M. Bolanowski, M. Rucha\u0142a, GO-QOL\u2014disease-specific quality of life questionnaire in Graves\u2019 orbitopathy. Endokrynol Polska 66(4), 362\u2013366 (2015)","journal-title":"Endokrynol Polska"},{"issue":"1","key":"855_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5603\/EP.2014.0008","volume":"65","author":"N Sawicka-Gutaj","year":"2014","unstructured":"N. Sawicka-Gutaj, P. Gutaj, J. Sowinski, E. Wender-Ozegowska, A. Czarnywojtek, J. Brazert, M. Ruchala, Influence of cigarette smoking on thyroid gland\u2014an update. Endokrynol Polska 65(1), 54\u201362 (2014)","journal-title":"Endokrynol Polska"},{"issue":"1","key":"855_CR22","first-page":"10","volume":"63","author":"N Sawicka","year":"2012","unstructured":"N. Sawicka, J. Sowinski, Correlation between thyroid volume and humoral thyroid autoimmunity after radioiodine therapy in Graves\u2019 disease. Endokrynol. Polska 63(1), 10 (2012)","journal-title":"Endokrynol. Polska"},{"key":"855_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102653","author":"B Jurecka-Lubieniecka","year":"2014","unstructured":"B. Jurecka-Lubieniecka, R. Ploski, D. Kula, K. Szymanski, T. Bednarczuk, U. Ambroziak, K. Hasse-Lazar, L. Hyla-Klekot, A. Tukiendorf, Z. Kolosza, Association between polymorphisms in the TSHR Gene and Graves\u2019 Orbitopathy. PLoS One (2014). doi: 10.1371\/journal.pone.0102653","journal-title":"PLoS One"},{"issue":"5","key":"855_CR24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.numecd.2015.01.003","volume":"25","author":"R Moli Le","year":"2015","unstructured":"R. Le Moli, V. Muscia, A. Tumminia, L. Frittitta, M. Buscema, F. Palermo, L. Sciacca, S. Squatrito, R. Vigneri, Type 2 diabetic patients with Graves\u2019 disease have more frequent and severe Graves\u2019 orbitopathy. Nutr. Metab. Cardiovasc. Dis. 25(5), 452\u2013457 (2015)","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"3","key":"855_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"L Bartalena","year":"2008","unstructured":"L. Bartalena, L. Baldeschi, A. Dickinson, A. Eckstein, P. Kendall-Taylor, C. Marcocci, M. Mourits, P. Perros, K. Boboridis, A. Boschi, Consensus statement of the European Group on Graves\u2019 orbitopathy (EUGOGO) on management of GO. Eur. J. Endocrinol. 158(3), 273\u2013285 (2008)","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"855_CR26","first-page":"942","volume":"19","author":"P Chomczynski","year":"1995","unstructured":"P. Chomczynski, K. Mackey, Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 19(6), 942\u2013945 (1995)","journal-title":"Biotechniques"},{"issue":"5","key":"855_CR27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5603\/EP.2014.0056","volume":"65","author":"P Miskiewicz","year":"2014","unstructured":"P. Miskiewicz, A. Kryczka, U. Ambroziak, B. Rutkowska, R. Glowczynska, G. Opolski, G. Kahaly, T. Bednarczuk, Is high dose intravenous methylprednisolone pulse therapy in patients with Graves\u2019 orbitopathy safe? Endokrynol. Polska 65(5), 402\u2013413 (2014)","journal-title":"Endokrynol. Polska"},{"issue":"5","key":"855_CR28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5603\/EP.2014.0054","volume":"65","author":"M Ruchala","year":"2014","unstructured":"M. Ruchala, A. Hernik, A. Zybek, Orbital radiotherapy in the management of Graves\u2019 orbitopathy\u2014current state of knowledge. Endokrynol. Polska 65(5), 388\u2013396 (2014)","journal-title":"Endokrynol. Polska"},{"key":"855_CR29","doi-asserted-by":"crossref","unstructured":"J.A. Garrity, R.S. Bahn, Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. Am. J. Ophthalmol. 142(1), 147\u2013153, e142 (2006)","DOI":"10.1016\/j.ajo.2006.02.047"},{"issue":"4","key":"855_CR30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1189\/jlb.0807581","volume":"83","author":"T Luk","year":"2008","unstructured":"T. Luk, Z. Malam, J.C. Marshall, Pre-B cell colony-enhancing factor (PBEF)\/visfatin: a novel mediator of innate immunity. J. Leukoc. Biol. 83(4), 804\u2013816 (2008)","journal-title":"J. Leukoc. Biol."},{"key":"855_CR31","doi-asserted-by":"crossref","first-page":"609593","DOI":"10.1155\/2015\/609593","volume":"2015","author":"J Shen","year":"2015","unstructured":"J. Shen, Z. Li, W. Li, Y. Ge, M. Xie, M. Lv, Y. Fan, Z. Chen, D. Zhao, Y. Han, Th1, Th2, and Th17 cytokine involvement in thyroid associated ophthalmopathy. Dis. Markers 2015, 609593 (2015)","journal-title":"Dis. Markers"},{"key":"855_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0322-7","author":"M Nowak","year":"2015","unstructured":"M. Nowak, L. Sieminska, J. Karpe, B. Marek, B. Kos-Kudla, D. Kajdaniuk, Serum concentrations of HGF and IL-8 in patients with active Graves\u2019 orbitopathy before and after methylprednisolone therapy. J. Endocrinol. Invest. (2015). doi: 10.1007\/s40618-015-0322-7","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"855_CR33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/JME-11-0006","volume":"46","author":"S Kumar","year":"2011","unstructured":"S. Kumar, S. Nadeem, M.N. Stan, M. Coenen, R.S. Bahn, A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves\u2019 ophthalmopathy. J. Mol. Endocrinol. 46(3), 155\u2013163 (2011)","journal-title":"J. Mol. Endocrinol."},{"issue":"1","key":"855_CR34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/thy.2009.0278","volume":"20","author":"S Kumar","year":"2010","unstructured":"S. Kumar, R. Schiefer, M.J. Coenen, R.S. Bahn, A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves\u2019 orbital preadipocyte fibroblasts. Thyroid 20(1), 59\u201365 (2010)","journal-title":"Thyroid"},{"issue":"12","key":"855_CR35","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/oby.2006.247","volume":"14","author":"YY Zhang","year":"2006","unstructured":"Y.Y. Zhang, L. Gottardo, R. Thompson, C. Powers, D. Nolan, J. Duffy, M.C. Marescotti, A. Avogaro, A. Doria, A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes. Obesity 14(12), 2119\u20132126 (2006)","journal-title":"Obesity"},{"key":"855_CR36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pharmthera.2015.02.004","volume":"151","author":"D Sampath","year":"2014","unstructured":"D. Sampath, T.S. Zabka, D.L. Misner, T. O\u2019Brien, P.S. Dragovich, Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer. Pharmacol. Ther. 151, 16\u201331 (2014)","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"855_CR37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cen.12527","volume":"81","author":"R Hoermann","year":"2014","unstructured":"R. Hoermann, J.E. Midgley, A. Giacobino, W.A. Eckl, H.G. Wahl, J.W. Dietrich, R. Larisch, Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment. Clin. Endocrinol. 81(6), 907\u2013915 (2014)","journal-title":"Clin. Endocrinol."},{"issue":"11","key":"855_CR38","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0034-1375678","volume":"46","author":"F Verburg","year":"2014","unstructured":"F. Verburg, U. Mader, I. Grelle, T. Visser, R. Peeters, J. Smit, C. Reiners, The thyroid axis \u2018setpoints\u2019 are significantly altered after long-term suppressive LT4 therapy. Horm. Metab. Res. 46(11), 794\u2013799 (2014)","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"855_CR39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/EJE-12-0819","volume":"168","author":"R Hoermann","year":"2013","unstructured":"R. Hoermann, J.E. Midgley, R. Larisch, J.W. Dietrich, Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment? Eur. J. Endocrinol. 168(2), 271\u2013280 (2013)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"855_CR40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/09513590.2014.964200","volume":"31","author":"J Sowinski","year":"2014","unstructured":"J. Sowinski, N. Sawicka-Gutaj, P. Gutaj, M. Ruchala, The role of free triiodothyronine in pathogenesis of infertility in levothyroxine-treated women with thyroid autoimmunity-a preliminary observational study. Gynecol. Endocrinol. 31(2), 116\u2013118 (2014)","journal-title":"Gynecol. Endocrinol."},{"issue":"5","key":"855_CR41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00125-007-0610-7","volume":"50","author":"K Lewandowski","year":"2007","unstructured":"K. Lewandowski, N. Stojanovic, M. Press, S. Tuck, K. Szosland, M. Bienkiewicz, M. Vatish, A. Lewinski, G. Prelevic, H.S. Randeva, Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 50(5), 1033\u20131037 (2007)","journal-title":"Diabetologia"},{"key":"855_CR42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/CS20050363","volume":"110","author":"K Krzyzanowska","year":"2006","unstructured":"K. Krzyzanowska, W. Krugluger, F. Mittermayer, R. Rahman, D. Haider, N. Shnawa, G. Schernthaner, Increased visfatin concentrations in women with gestational diabetes mellitus. Clin. Sci. 110, 605\u2013609 (2006)","journal-title":"Clin. Sci."},{"issue":"2","key":"855_CR43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/EJE-07-0633","volume":"158","author":"K Choi","year":"2008","unstructured":"K. Choi, J. Lee, E. Kim, S. Baik, H. Seo, D. Choi, D. Oh, C. Park, Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur. J. Endocrinol. 158(2), 203\u2013207 (2008)","journal-title":"Eur. J. Endocrinol."},{"key":"855_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-3-642-17214-4_7","volume":"203","author":"A Garten","year":"2011","unstructured":"A. Garten, S. Petzold, S. Schuster, A. Korner, J. Kratzsch, W. Kiess, Nampt and its potential role in inflammation and type 2 diabetes. Handb. Exp. Pharmacol. 203, 147\u2013164 (2011). doi: 10.1007\/978-3-642-17214-4_7","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"855_CR45","doi-asserted-by":"crossref","first-page":"E293","DOI":"10.1210\/jc.2012-2818","volume":"98","author":"I Kowalska","year":"2013","unstructured":"I. Kowalska, M. Karczewska-Kupczewska, A. Adamska, A. Nikolajuk, E. Otziomek, M. Straczkowski, Serum visfatin is differentially regulated by insulin and free fatty acids in healthy men. J. Clin. Endocrinol. Metab. 98(2), E293\u2013E297 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"855_CR46","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/humrep\/dem118","volume":"22","author":"I Kowalska","year":"2007","unstructured":"I. Kowalska, M. Straczkowski, A. Nikolajuk, A. Adamska, M. Karczewska-Kupczewska, E. Otziomek, S. Wolczynski, M. Gorska, Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum. Reprod. 22(7), 1824\u20131829 (2007)","journal-title":"Hum. Reprod."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0855-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-015-0855-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0855-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T13:17:50Z","timestamp":1567516670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-015-0855-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["855"],"URL":"https:\/\/doi.org\/10.1007\/s12020-015-0855-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"type":"print","value":"1355-008X"},{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2016,1,14]]}}}